Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03939819 · ClinicalTrials.gov registry record · NA

Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
106
Enrollment target

NCT03939819 is a NA study that has completed, run by Emory University. The registered enrollment target is 106 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03939819, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

This study aims to compare the difference in staple usage and post-operative GERD (heartburn) between patients that had an endoscope used versus patients that had a suction calibration system used on them during "laparoscopic sleeve gastrectomy" (LSG).

Interventions

  • DEVICE ViSiGi® 3D suction calibration device
  • DEVICE Esophagogastroduodenoscopy (EGD) calibration

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2019-07-30
Est. Completion 2022-02-02
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT03939819

The ClinicalTrials.gov registry entry for NCT03939819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ViSiGi® 3D suction calibration device is the first listed.

NCT03939819 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03939819 about?

NCT03939819 is a clinical study titled "Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy". This study aims to compare the difference in staple usage and post-operative GERD (heartburn) between patients that had an endoscope used versus patients that had a suction calibration system used on them during "laparoscopic sleeve gastrectomy" (LSG).

What is the current status of trial NCT03939819?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2019-07-30. Estimated completion is 2022-02-02.

What interventions are being tested in trial NCT03939819?

The interventions under investigation include: ViSiGi® 3D suction calibration device (DEVICE), Esophagogastroduodenoscopy (EGD) calibration (DEVICE).

Who is sponsoring clinical trial NCT03939819?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.